Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Injecting allovectin-7 into a person's melanoma cells may make the
body build an immune response that will kill tumor cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of dacarbazine with or
without immunotherapy in treating patients who have stage III or stage IV melanoma.